Yannis Tsouderos
Overview
Explore the profile of Yannis Tsouderos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reginster J, Cooper C, Rizzoli R, Kanis J, Appelboom G, Bautmans I, et al.
Aging Clin Exp Res
. 2016 Jan;
28(1):47-58.
PMID: 26717937
Purpose: Sarcopenia is an age-related muscle condition which is frequently a precursor of frailty, mobility disability and premature death. It has a high prevalence in older populations and presents a...
2.
Arden N, Richette P, Cooper C, Bruyere O, Abadie E, Branco J, et al.
Drugs Aging
. 2015 Jun;
32(7):525-35.
PMID: 26085027
Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal candidate for personalized healthcare. The aim of the discussions of the European Society for Clinical and Economic Aspects...
3.
Hiligsmann M, Cooper C, Arden N, Boers M, Branco J, Brandi M, et al.
Semin Arthritis Rheum
. 2013 Sep;
43(3):303-13.
PMID: 23992801
Objectives: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. Methods: The ESCEO expert working group met to discuss...
4.
Rizzoli R, Reginster J, Arnal J, Bautmans I, Beaudart C, Bischoff-Ferrari H, et al.
Calcif Tissue Int
. 2013 Jul;
93(2):101-20.
PMID: 23828275
The reduced muscle mass and impaired muscle performance that define sarcopenia in older individuals are associated with increased risk of physical limitation and a variety of chronic diseases. They may...
5.
Vincent L, Guardiola B, Tsouderos Y, Canet E
Lancet
. 2011 Jun;
377(9782):2003.
PMID: 21665033
No abstract available.
6.
Smolen J, Boers M, Abadie E, Breedveld F, Emery P, Bardin T, et al.
Curr Med Res Opin
. 2010 Dec;
27(2):315-25.
PMID: 21142618
Since 2003, the European Medicines Agency (EMA) document, 'Points to consider on clinical investigation of medicinal products other than NSAIDs (nonsteroidal anti-inflammatory drugs) for the treatment of rheumatoid arthritis' has...
7.
Belissa-Chatelain P, Dupin-Roger I, Cournarie F, Tsouderos Y
Bone
. 2009 Jul;
45(5):1024-5.
PMID: 19616656
No abstract available.
8.
Reginster J, Abadie E, Delmas P, Rizzoli R, Dere W, der Auwera P, et al.
Osteoporos Int
. 2005 Aug;
17(1):1-7.
PMID: 16091835
Recent advances in the understanding of the epidemiology of osteoporosis suggest that certain parts of the current European guidelines for the registration of drugs in osteoporosis might be no longer...
9.
Abadie E, Devogealer J, Ringe J, Ethgen D, Bouvenot G, Kreutz G, et al.
Semin Arthritis Rheum
. 2005 Aug;
35(1):1-4.
PMID: 16084217
Objectives: The Group for the Respect and Excellence in Science (GREES) has reviewed and updated their recommendations for clinical trials to evaluate the efficacy and safety of new chemical entities...
10.
Canet E, Tsouderos Y, Perret L
Med Sci (Paris)
. 2004 Oct;
20(10):935-7.
PMID: 15461975
No abstract available.